IGFBP2 and glioblastoma: This study developed a prognostic signature using hypoxia-related differentially expressed genes (DEGs) in Glioblastoma Multiforme (GBM) and identified three optimal gene signatures (CP, IGFBP2, and LOX) using multi-omics analysis.